Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Jaehong Key

Jaehong Key, Ph.D.

Jaehong Key, Ph.D.

Jaehong Key, Ph.D.

Postdoctoral Fellow
The Methodist Hospital Research Institute

E-mail: jkey@houstonmethodist.org
Phone: 713-441-8801
Fax: 713-790-3033


Education

B.S.   Biomedical Engineering, Yonsei University, Korea
M.S.   Biomedical Engineering, Yonsei University, Korea
Ph.D.   Biomedical Engineering, Purdue University, United States
 

 

Biography

Dr. Key joined The Methodist Hospital Research Institute in May, 2012. He graduated from the Biomedical Engineering (BME) department at Yonsei University in South Korea with an undergraduate degree in 2002 and a Master’s degree in 2007.  During his Master’s study, he also worked as a student researcher at the Korea Institute of Science and Technology (KIST), where he studied 3-dimensional image registration techniques for the development of an image-guided surgery system for total knee replacement (TKR).  He graduated from the Weldon School of Biomedical Engineering at Purdue University with a Doctor of Philosophy degree in 2012.  During his Ph.D. course, he developed magnetic and fluorescent dual-modality nanoparticles for in vivo cancer imaging.  He is currently focusing on the development of new nanoparticles for biomedical imaging and therapy.

Description of Research

  • Development of organic and inorganic nanoparticles for cancer diagnosis and therapy
  • In-vitro and -vivo multi-modal imaging of cancer using nanoparticles
  • Bio-distribution study of nanoparticles in the body

Major Areas of Research

Nanomedicine, Magnetic Resonance Imaging, Optical Imaging, Cancer Diagnosis and Therapy

Recent Publications

Key J, Cooper C, Kim AY, Dhawan D, Knapp DW, Kim K, Choi K, Kwon IC, Park K, Leary JF, “In vivo NIRF and MR dual-modality imaging using glycol chitosan nanoparticles”, Journal of Controlled Drug Release, 2012; In review

Key J, Dhawan D, Knapp DW, Kim K, Kwon IC, Choi K, Leary JF, “MRI and NIRF imaging of murine bladder tumor using chitosan based nanocarriers for MRI based cancer detection and NIRF imaging guided cancer removal, Molecular Cancer, 2012; To be submitted

Key J, Leary JF, “Nanoparticles for Multimodality In Vivo Imaging in Nanomedicine, Journal of Nanomedicine and Nanotechnology, 2012; To be submitted

Key J, Dhawan D, Knapp DW, Kim K, Kwon IC, Choi K, Leary JF, “Multimodal in-vivo MRI and NIRF imaging of bladder tumor using peptide conjugated glycol chitosan nanoparticles”, vol. 8225, Proc. of SPIE, 2012, USA

Key J, Dhawan D, Knapp DW, Kim K, Kwon IC, Choi K, Leary JF, “Design of peptide-conjugated glycol chitosan nanoparticles for near infrared fluorescent (NIRF) in-vivo imaging of bladder tumors”, vol. 8233, Proc. of SPIE, 2012, USA (invited paper)

Key J, Kim K, Dhawan D, Knapp DW, Kwon IC, Choi K, Leary JF, “Dual-modality in vivo imaging for MRI detection of tumors and NIRF guided surgery using multi-component nanoparticles, Proc. of SPIE, vol. 7908, 790805, 2011, USA